Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy PROXIMA™ Hip in Subjects With Indications Suitable for a Primary Total Hip Arthroplasty

NCT01134445 is registered in ClinicalTrials.gov with DePuy International as lead sponsor.

NCT NCT01134445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01134445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy PROXIMA™ Hip in Subjects With Indications Suitable for a Primary Total Hip Arthroplasty
Lead sponsor
DePuy International
Phase
Phase 4
Overall status
Terminated
Start date
February 1, 2010
Completion date
June 1, 2016
Enrollment
42 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, congenital hip dysplasia, osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, traumatic femoral fractures